Health News Archive - May 17, 2011
JACKSONVILLE, Fla. and HARTFORD, Conn., May 17, 2011 /PRNewswire/ -- Blue Cross and Blue Shield of Florida (BCBSF), Inc.
HARBIN, China, May 17, 2011 /PRNewswire-Asia/ -- China Botanic Pharmaceutical Inc.
ADDISON, Texas, May 17, 2011 /PRNewswire/ -- ULURU Inc.
AURORA, Ill., May 17, 2011 /PRNewswire/ -- UMC, Inc. (UMCN: PK), a provider of revenue cycle management solutions to hospitals, physician group practices, clinics, and other healthcare providers, formally announces today the appointments of Patrick B.
GRAND RAPIDS, Mich., May 17, 2011 /PRNewswire/ -- Leadership from Van Andel Research Institute (VARI) today announced the creation of the VARI Pediatric Cancer Translational Research Program, which will unite basic research and clinical care through a nationwide consortium of partners.
AUSTIN, Texas, May 17, 2011 /PRNewswire/ -- Rules-Based Medicine (RBM), a global leader in biomarker testing services, today announced the acquisition of intellectual property assets from Satoris, Inc.
SAN DIEGO, May 17, 2011 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it received the CLARUS Award presented by MDB Capital Group at the second annual Bright Lights Conference in New York City on May 10th.
BURLINGTON, Vt., May 17, 2011 /PRNewswire/ -- PureWellness, an industry leader in providing online wellness solutions, announced the release of its ground breaking Risk Advisor.
TEL AVIV, Israel, May 17, 2011 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard(TM) mesh protective stent system, today announced that it has filed its Form 10-Q for the three months ended March 31, 2011 with the U.S.
NEW YORK, May 17, 2011 /PRNewswire/ -- This season Dr. Bruce Katz, Director of JUVA Skin and Laser Center in New York, is advising his patients who have spider veins to show off their skin thanks to a new injectable treatment called Asclera(TM).